This inventor holds 18 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Cydex Pharmaceuticals, Inc.. Active years: 2009-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2026
Title: Celebrating the Innovations of Vincent D. Antle
Introduction
Vincent D. Antle, an accomplished inventor based in Olathe, Kansas, has made significant contributions to the field of pharmaceuticals through his innovative work. With 16 patents to his name, Antle has developed unique compounds that have the potential to advance drug formulation and delivery methods.
Latest Patents
Among his latest contributions are two notable patents. The first is for sulfoalkyl ether cyclodextrin compositions, which offer methods of making and employing these innovative compositions. These compositions consist of a sulfoalkyl ether cyclodextrin with a low absorption due to drug-degrading agents, making them promising for pharmaceutical applications. The second patent focuses on fractionated alkylated cyclodextrin compositions featuring a single degree of substitution, detailing processes for their preparation and application. These inventions exemplify Antle's commitment to enhancing drug efficacy and stability.
Career Highlights
Vincent D. Antle has dedicated his career to advancing pharmaceutical science, particularly while working at Cydex Pharmaceuticals, Inc. His expertise in chemical engineering and passion for innovation have positioned him as a leader in developing advanced cyclodextrin-based products.
Collaborations
Throughout his career, Antle has worked alongside talented colleagues, including Daniel Monteiro and Jose R. Matos. Their collaborative efforts have contributed to the successful development of various formulations and have fostered a stimulating environment of innovation within their team.
Conclusion
Vincent D. Antle's pioneering work and extensive patent portfolio reflect his significant role in the landscape of pharmaceutical innovation. His contributions not only highlight his individual talents but also underscore the importance of collaboration in driving advancements in drug formulation techniques. As the field of pharmaceuticals continues to evolve, Antle will undoubtedly remain a key figure in the pursuit of novel solutions for healthcare challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile